Founded by cardiologists for cardiologists: of course we’re looking forward to learning and connecting at TCT 2023.

The Transcatheter Cardiovascular Therapeutics (TCT) meeting is the world’s largest educational meeting specializing in interventional cardiovascular medicine. This year, it will take place on October 23-26, 2023 back in San Francisco, California.   “We look forward to connecting with sponsors, clinician innovators and regulatory officials at TCT 2023 to further understand the latest in transcatheter…

Venture Funding for New, “University Bred” Medical Technologies: When It’s Time and What to Bring

If you’ve been following our funding series for innovators seeking to spin out new medical technologies from higher ed “environments” like Georgia Tech, you’ll have seen:   The Top 5 Medtech and Life Science Funding Resources for GT Faculty, Researchers and Investigators – at Phase Zero, THE Place to Start, and Follow-On, for University Sourced…

The GCMI 2023 State of Medtech Design and Development Report: Part 1

Innovation in medical technologies is something of a paradox. On one hand, new technologies that drive innovation can manifest at breakneck speed. On the other hand, the pace at which those technologies breed innovations that reach full commercialization and patient impact can be glacial by comparison.   What have been the most significant changes with…

THE Place to Start, And Follow-On, For University-Sourced Medtech Innovation Funding

A dive into the Georgia Research Alliance (GRA) and its funding programs with GRA VP of Venture Development Ashley Cornelison In the first of this short series on medtech innovation funding opportunities, GCMI Director of Scientific Affairs Evan Goldberg stated, “GRA is the first place to go for those trying to commercialize a technology out…

When ROI Gets Squeezed By Market Size, Process In Medtech Innovation Means Even More

Revolutionizing Pediatrics: Innovations in Medical Device Design & Development. A Pediatric Tech Talk Webinar with GCMI, June 21, 2023 – 12:00 p.m. Eastern   “Innovation in pediatric technologies that address unmet clinical needs lags behind innovation for adult populations in large part due to its relatively small market size and ROI (return on investment) prospects…

Let’s Talk Innovation, Including Preclinical for Artificial Organ Technologies, at ASAIO 2023

Evaluating your new artificial organ technology’s readiness for preclinical work or just want to get together to talk about the latest in preclinical testing, bioskills training or medtech innovation across the board? Connect with GCMI and T3 Labs at ASAIO 2023. At GCMI, medtech and medical device innovation are at the core of our efforts…

Preclinical Implications for Existing, and New Circulatory Assist Devices

The National Center for Biotechnology Information describes mechanical circulatory assist devices as, “commonly used in the treatment of severe heart failure as bridges to cardiac transplant, as destination therapy for patients who are not transplant candidates, and as bridges to recovery and “decision-making.” These devices, which can be used to support the left or right…

Moving Beyond Improvisation. Solving a High Volume, High Value Unmet Clinical Need to Advance Patient Care

A “Catheter Gripping Tool” solving an unmet need as GCMI’s grows its roster of collaborative medtech innovations with the Children’s Mercy Kansas City Center for Pediatric Innovation.   Human beings are generally good at improvisation. Assembly calls for a 10mm socket? Try this handy crescent wrench right here and maybe it will do. What happened…

Can Preclinical Studies Actually Be Agile?

Quick Insights Aligned in Acceleration: Indeed, the Most Expensive Preclinical Study is the One You Have to Do Twice As mentioned in a post last month, our colleagues at Within3 are using technology to accelerate pharma and medtech innovation in some very interesting ways, all of which center around actionable insights generation and insights management. …

Beware the Unfamiliar Approach: Preclinical Implications for Novel Cell & Gene Therapies

Roughly one decade ago, scientists made significant improvements in viral vectors’ ability to deliver genetic therapeutics. Those therapies use genetic material like DNA to manipulate a patients’ own cells. Cellular (cell) therapies transfer cells into the patient whether they are the patients’ own cells or cells derived from another location or donor cells.    Because…